,5 The CD33-related Silane-Acid-Binding Immunoglobulin-like Lectin 9 (SIGLEC9) is of particular interest in tumor immunotherapy,6 which showed high affinity for α−2,3 and α−2,6 binding sialoglycans.7 Here, SIGLEC9 is linked to neoplasm.